Related Experiment Videos
Spinal muscular atrophy: new thoughts on the pathogenesis and classification schema
B S Russman1, S T Iannacone, C R Buncher
1Newington Children's Hospital, CT 06111.
Journal of Child Neurology
|October 1, 1992
Summary
This study challenges the current classification of spinal muscular atrophy (SMA), a common childhood neuromuscular disease. Findings suggest SMA functional loss may not involve cell death, offering new insights into disease progression.
Area of Science:
- Neurology
- Pediatric Medicine
- Genetics
Background:
- Spinal muscular atrophy (SMA) is the second most frequent neuromuscular disorder in childhood.
- Existing classification systems for SMA may not accurately reflect disease progression or patient outcomes.
Purpose of the Study:
- To conduct the first prospective, collaborative study on spinal muscular atrophy (SMA).
- To re-evaluate the validity of current SMA classification schemas.
- To investigate the mechanisms underlying functional loss in SMA patients.
Main Methods:
- Prospective evaluation of 141 SMA patients over 3 years.
- Grouping patients by age of onset and initial functional status.
- Serial muscle strength assessments using myometry in 96 patients aged 5+ years.
- Functional assessments over an 18-month period for 37 patients.
Main Results:
- The study identified limitations in the current SMA classification system, with patients exhibiting a wider age range than expected.
- 49 patients with early-onset SMA (type I) survived well beyond the typical 2-4 year lifespan.
- Over 18 months, 37 patients maintained muscle strength but experienced functional decline, suggesting a non-cell death mechanism.
Conclusions:
- The current classification of spinal muscular atrophy (SMA) requires revision.
- Functional deterioration in SMA may occur independently of muscle strength loss.
- A novel mechanism, distinct from cell death, might explain functional decline in SMA, preserving muscle strength while hindering motor unit development.